Deepak Raina
Overview
Explore the profile of Deepak Raina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1422
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raina D, Chandrashekhara S, Voyles R, Wachs J, Saha S
IEEE Trans Ultrason Ferroelectr Freq Control
. 2024 Apr;
71(11):1451-1463.
PMID: 38598406
Autonomous ultrasound image quality assessment (US-IQA) is a promising tool to aid the interpretation by practicing sonographers and to enable the future robotization of ultrasound procedures. However, autonomous US-IQA has...
2.
Chandrashekhara S, Rangarajan K, Agrawal A, Thulkar S, Gamanagatti S, Raina D, et al.
World J Methodol
. 2022 Sep;
12(4):274-284.
PMID: 36159101
Background: Performing ultrasound during the current pandemic time is quite challenging. To reduce the chances of cross-infection and keep healthcare workers safe, a robotic ultrasound system was developed, which can...
3.
Rajabi H, Hata T, Li W, Long M, Hu Q, Liu S, et al.
Oncogene
. 2019 Oct;
38(47):7278.
PMID: 31576011
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
4.
Rajabi H, Hata T, Li W, Long M, Hu Q, Liu S, et al.
Oncogene
. 2019 Aug;
38(47):7266-7277.
PMID: 31435022
RASSF1A encodes a tumor suppressor that inhibits the RAS→RAF→MEK→ERK pathway and is one of the most frequently inactivated genes in human cancers. MUC1-C is an oncogenic effector of the cancer...
5.
Dawar H, Mugalakhod V, Wani J, Raina D, Rastogi S, Wani S
Acta Orthop Belg
. 2018 Nov;
83(3):488-494.
PMID: 30423653
Osteopetrosis is a disorder of diminished bone resorption with hard and brittle bones resulting in high rates of perioperative complications during an operative intervention. We present a series of 4...
6.
Panchamoorthy G, Jin C, Raina D, Bharti A, Yamamoto M, Adeebge D, et al.
JCI Insight
. 2018 Jun;
3(12).
PMID: 29925694
Mucin 1 (MUC1) is a heterodimeric protein that is aberrantly overexpressed on the surface of diverse human carcinomas and is an attractive target for the development of mAb-based therapeutics. However,...
7.
Raina D, Agarwal P, Lee J, Bharti A, McKnight C, Sharma P, et al.
PLoS One
. 2015 Aug;
10(8):e0135156.
PMID: 26267657
Mucin 1 (MUC1) is a heterodimeric protein that is aberrantly expressed in diverse human carcinomas and certain hematologic malignancies. The oncogenic MUC1 transmembrane C-terminal subunit (MUC1-C) functions in part by...
8.
Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation
Hasegawa M, Sinha R, Kumar M, Alam M, Yin L, Raina D, et al.
Clin Cancer Res
. 2015 Feb;
21(10):2338-47.
PMID: 25712682
Purpose: The MUC1-C oncoprotein is an intracellular target that is druggable with cell-penetrating peptide inhibitors. However, development of peptidyl drugs for treating cancer has been a challenge because of unfavorable...
9.
Kharbanda A, Rajabi H, Jin C, Raina D, Kufe D
Mol Cancer Res
. 2013 Mar;
11(7):714-23.
PMID: 23538857
Tamoxifen resistance of estrogen receptor-positive (ER+) breast cancer cells has been linked in part to activation of receptor tyrosine kinases, such as HER2, and the PI3K-AKT pathway. Mucin 1 (MUC1)...
10.
Uchida Y, Raina D, Kharbanda S, Kufe D
Cancer Biol Ther
. 2012 Nov;
14(2):127-34.
PMID: 23114713
Mucin 1 (MUC1) is a heterodimeric glycoprotein that is aberrantly overexpressed in most human breast cancers. The oncogenic MUC1-C subunit promotes survival and blocks the apoptotic response to genotoxic anticancer...